Back to Research Updates
Nutrition, diabetes, and metabolism

Can an 8-hour eating window improve type 1 diabetes control?

A concise summary of the ScienceDaily report, with the original research cited below.

Adult with type 1 diabetes at a meal with a conceptual eating window and glucose monitoring
Read the original researchRead the science-news report
Note

This educational research summary does not replace individual medical or nutrition advice.

Science-news source: ScienceDaily

Eating only 8 hours a day may help control Type 1 diabetes

News publication date: September 10, 2026

News summary

ScienceDaily reported on a new six-month randomized trial in 32 adults with type 1 diabetes and overweight or obesity. Participants were assigned to one of three groups: eating only between noon and 8 p.m. without calorie counting, reducing daily energy intake by about 25%, or making no change to their usual routine. The primary outcome was body weight, and time-restricted eating was not significantly better for weight loss than calorie restriction or the control condition. However, HbA1c fell by about 0.46 percentage points more with the 8-hour eating window than with calorie restriction. The study also found no significant increase in diabetic ketoacidosis, severe hypoglycemia, or severe hyperglycemia. The finding is promising, but it is preliminary and does not support changing eating patterns in type 1 diabetes without medical supervision.

Original research title

Efficacy and Safety of Time-Restricted Eating in Adults With Type 1 Diabetes: A Randomized Controlled Trial

After six months, weight loss with time-restricted eating was not significantly different from calorie restriction or the control condition. HbA1c, however, was 0.46 percentage points lower with the 8-hour eating window than with calorie restriction. Mean glucose and total insulin dose did not differ significantly across groups.

The study does not show that intermittent fasting or unsupervised restriction of eating time is safe or appropriate for everyone with type 1 diabetes. Meal timing may need to be coordinated carefully with insulin dosing, glucose monitoring, and individual clinical circumstances. At this stage, the result is better viewed as a promising direction for larger trials than as a general treatment recommendation.

The sample included only 32 participants and follow-up lasted six months. All participants were adults with type 1 diabetes plus overweight or obesity, so the findings cannot be generalized to everyone with type 1 diabetes. Safety was also assessed under trial monitoring, which is not the same as unsupervised use in everyday life.

Discussion

Comments

Share your view on this research update.

Please do not include private medical or contact information.

Loading comments…